Cardinal Health to announce FY26 results on August 11

0 min read Updated on 09 Jul 2026, 04:46 PM

Reviewed by

Naman SScanX News Team

AI Summary

Cardinal Health will release its fourth-quarter and fiscal year 2026 financial results on August 11 before the market opens. A webcast to discuss the results will begin at 8:30 a.m. Eastern, accessible via the company's Investor Relations page. Presentation slides and a replay will be available for 12 months.

*this image is generated using AI for illustrative purposes only.

Cardinal Health plans to release its fourth-quarter and fiscal year 2026 financial results on August 11, prior to the opening of trading on the New York Stock Exchange. The announcement will provide insights into the company's performance for the final quarter and the full fiscal year. A webcast to discuss these results is scheduled to begin at 8:30 a.m. Eastern.

Investors and stakeholders can access the live webcast and the corresponding slide presentation through Cardinal Health's Investor Relations page. No access code is required to view the broadcast. Following the event, the presentation slides and a webcast replay will remain accessible on the Investor Relations page for 12 months.

Key Event Details

Event	Date	Time
Financial Results Release	August 11	Before market open
Investor Webcast	August 11	8:30 a.m. Eastern

Cardinal Health operates as a distributor of pharmaceuticals and specialty products, a supplier of home-health and direct-to-patient products and services, and a global manufacturer and distributor of medical and laboratory products. The company also provides performance and data solutions and operates nuclear pharmacies and manufacturing facilities.

What strategic initiatives will Cardinal Health highlight to drive growth in fiscal year 2027?

How might the financial results impact Cardinal Health's stock performance and investor sentiment?

What challenges or opportunities in the pharmaceutical and medical products distribution sectors could influence future earnings?

Rating and Target Details

The firm's decision to uphold the Buy rating suggests confidence in Cardinal Health's operational strength and future growth prospects. The increased price target indicates an expectation of further upside in the stock's value.

Metric	Value
Rating	Buy
Previous Price Target	$240
New Price Target	$260

Analyst Perspective

Allen Lutz's recommendation underscores a positive sentiment toward Cardinal Health's strategic positioning. The revised target price serves as a benchmark for investors assessing the stock's potential trajectory.

What specific operational factors are driving the increased confidence in Cardinal Health's growth prospects?

How might Cardinal Health's strategic positioning evolve to meet the revised price target expectations?

What potential market trends could further support the stock's upward trajectory?